| Secondary |
| Drug Use For Unknown Indication |
31.9% |
| Hypertension |
18.1% |
| Product Used For Unknown Indication |
13.9% |
| Type 2 Diabetes Mellitus |
3.9% |
| Lung Infection |
2.8% |
| Micturition Disorder |
2.8% |
| Respiratory Tract Infection |
2.8% |
| Dementia Alzheimer's Type |
2.3% |
| Pulmonary Embolism |
2.3% |
| Thrombocytopenic Purpura |
2.3% |
| Anxiety |
2.1% |
| Essential Hypertension |
2.1% |
| Benign Prostatic Hyperplasia |
1.9% |
| Cardiac Failure |
1.9% |
| Insomnia |
1.9% |
| Depression |
1.6% |
| Intervertebral Discitis |
1.4% |
| Oedema |
1.4% |
| Pain |
1.4% |
| Prophylaxis |
1.4% |
|
| Vomiting |
17.6% |
| Eczema |
9.4% |
| Syncope |
9.4% |
| Agranulocytosis |
5.9% |
| Renal Failure |
5.9% |
| Renal Failure Acute |
5.9% |
| Rhabdomyolysis |
5.9% |
| Thrombocytopenia |
4.7% |
| Toxic Skin Eruption |
4.7% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
3.5% |
| Myalgia |
3.5% |
| Pitting Oedema |
3.5% |
| Wheezing |
3.5% |
| Anaemia Haemolytic Autoimmune |
2.4% |
| Cholestasis |
2.4% |
| Head Injury |
2.4% |
| Hodgkin's Disease |
2.4% |
| Lung Disorder |
2.4% |
| Myocardial Infarction |
2.4% |
| Neurological Decompensation |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
26.3% |
| Hypertension |
22.3% |
| Drug Use For Unknown Indication |
16.9% |
| Type 2 Diabetes Mellitus |
4.5% |
| Atrial Fibrillation |
3.4% |
| Diabetes Mellitus |
3.1% |
| Multiple Myeloma |
2.6% |
| Thrombosis Prophylaxis |
2.6% |
| Prophylaxis |
2.0% |
| Pain |
2.0% |
| Dyslipidaemia |
1.9% |
| Essential Hypertension |
1.7% |
| Bronchitis |
1.5% |
| Hypercholesterolaemia |
1.5% |
| Depression |
1.4% |
| Premedication |
1.4% |
| Hepatitis C |
1.3% |
| Anxiety |
1.2% |
| Hiv Infection |
1.1% |
| Rheumatoid Arthritis |
1.1% |
|
| Renal Failure Acute |
16.8% |
| Vomiting |
8.7% |
| Renal Failure |
8.1% |
| Thrombocytopenia |
6.9% |
| Toxic Skin Eruption |
6.9% |
| Hypoglycaemia |
5.2% |
| Hepatocellular Injury |
4.6% |
| Rectal Haemorrhage |
4.6% |
| Somnolence |
4.6% |
| Weight Decreased |
4.6% |
| Malaise |
4.0% |
| Agranulocytosis |
2.9% |
| Hyponatraemia |
2.9% |
| Purpura |
2.9% |
| Pyrexia |
2.9% |
| Renal Impairment |
2.9% |
| Rhabdomyolysis |
2.9% |
| Urinary Retention |
2.9% |
| Drug Ineffective |
2.3% |
| Dyspnoea |
2.3% |
|
| Interacting |
| Hypertension |
50.0% |
| Diuretic Therapy |
25.0% |
| Polymyalgia Rheumatica |
25.0% |
|
| Renal Failure Acute |
100.0% |
|
